United States Unfractionated Heparin Market Report 2017

2017-07-17 / 3800.00 / Pharma & Healthcare / 103 Pages

Description

In this report, the United States Unfractionated Heparin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Unfractionated Heparin in these regions, from 2012 to 2022 (forecast).

United States Unfractionated Heparin market competition by top manufacturers/players, with Unfractionated Heparin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Bayer Healthcare AG
GlaxoSmithKline
Boehringer Ingelheim
Sanofi S.A
Abbott
Baxter
...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Oral Drug
Injection Drug
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Unfractionated Heparin for each application, including
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content

Table of Contents

United States Unfractionated Heparin Market Report 2017
1 Unfractionated Heparin Overview
1.1 Product Overview and Scope of Unfractionated Heparin
1.2 Classification of Unfractionated Heparin by Product Category
1.2.1 United States Unfractionated Heparin Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Unfractionated Heparin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Oral Drug
1.2.4 Injection Drug
1.3 United States Unfractionated Heparin Market by Application/End Users
1.3.1 United States Unfractionated Heparin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.4 United States Unfractionated Heparin Market by Region
1.4.1 United States Unfractionated Heparin Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Unfractionated Heparin Status and Prospect (2012-2022)
1.4.3 Southwest Unfractionated Heparin Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Unfractionated Heparin Status and Prospect (2012-2022)
1.4.5 New England Unfractionated Heparin Status and Prospect (2012-2022)
1.4.6 The South Unfractionated Heparin Status and Prospect (2012-2022)
1.4.7 The Midwest Unfractionated Heparin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Unfractionated Heparin (2012-2022)
1.5.1 United States Unfractionated Heparin Sales and Growth Rate (2012-2022)
1.5.2 United States Unfractionated Heparin Revenue and Growth Rate (2012-2022)

2 United States Unfractionated Heparin Market Competition by Players/Suppliers
2.1 United States Unfractionated Heparin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Unfractionated Heparin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Unfractionated Heparin Average Price by Players/Suppliers (2012-2017)
2.4 United States Unfractionated Heparin Market Competitive Situation and Trends
2.4.1 United States Unfractionated Heparin Market Concentration Rate
2.4.2 United States Unfractionated Heparin Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Unfractionated Heparin Manufacturing Base Distribution, Sales Area, Product Type

3 United States Unfractionated Heparin Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Unfractionated Heparin Sales and Market Share by Region (2012-2017)
3.2 United States Unfractionated Heparin Revenue and Market Share by Region (2012-2017)
3.3 United States Unfractionated Heparin Price by Region (2012-2017)

4 United States Unfractionated Heparin Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Unfractionated Heparin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Unfractionated Heparin Revenue and Market Share by Type (2012-2017)
4.3 United States Unfractionated Heparin Price by Type (2012-2017)
4.4 United States Unfractionated Heparin Sales Growth Rate by Type (2012-2017)

5 United States Unfractionated Heparin Sales (Volume) by Application (2012-2017)
5.1 United States Unfractionated Heparin Sales and Market Share by Application (2012-2017)
5.2 United States Unfractionated Heparin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Unfractionated Heparin Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Unfractionated Heparin Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bayer Healthcare AG
6.2.2 Unfractionated Heparin Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bayer Healthcare AG Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline
6.3.2 Unfractionated Heparin Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GlaxoSmithKline Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim
6.4.2 Unfractionated Heparin Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Boehringer Ingelheim Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Sanofi S.A
6.5.2 Unfractionated Heparin Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sanofi S.A Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Abbott
6.6.2 Unfractionated Heparin Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Abbott Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Baxter
6.7.2 Unfractionated Heparin Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Baxter Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
...

7 Unfractionated Heparin Manufacturing Cost Analysis
7.1 Unfractionated Heparin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Unfractionated Heparin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Unfractionated Heparin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Unfractionated Heparin Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Unfractionated Heparin Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Unfractionated Heparin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Unfractionated Heparin Sales Volume Forecast by Type (2017-2022)
11.3 United States Unfractionated Heparin Sales Volume Forecast by Application (2017-2022)
11.4 United States Unfractionated Heparin Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Product Picture of Unfractionated Heparin
Figure United States Unfractionated Heparin Market Size (K MT) by Type (2012-2022)
Figure United States Unfractionated Heparin Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Drug Product Picture
Figure Injection Drug Product Picture
Figure United States Unfractionated Heparin Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Unfractionated Heparin by Application in 2016
Figure Treatment of Venous Thromboembolism Examples
Table Key Downstream Customer in Treatment of Venous Thromboembolism
Figure Complications of Pregnancy Examples
Table Key Downstream Customer in Complications of Pregnancy
Figure Cardioversion of Atrial Fibrillation/Flutter Examples
Table Key Downstream Customer in Cardioversion of Atrial Fibrillation/Flutter
Figure United States Unfractionated Heparin Market Size (Million USD) by Region (2012-2022)
Figure The West Unfractionated Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Unfractionated Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Unfractionated Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Unfractionated Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Unfractionated Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Unfractionated Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Unfractionated Heparin Sales (K MT) and Growth Rate (2012-2022)
Figure United States Unfractionated Heparin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Unfractionated Heparin Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Unfractionated Heparin Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Unfractionated Heparin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Unfractionated Heparin Sales Share by Players/Suppliers
Figure 2017 United States Unfractionated Heparin Sales Share by Players/Suppliers
Figure United States Unfractionated Heparin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Unfractionated Heparin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Unfractionated Heparin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Unfractionated Heparin Revenue Share by Players/Suppliers
Figure 2017 United States Unfractionated Heparin Revenue Share by Players/Suppliers
Table United States Market Unfractionated Heparin Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Unfractionated Heparin Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Unfractionated Heparin Market Share of Top 3 Players/Suppliers
Figure United States Unfractionated Heparin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Unfractionated Heparin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Unfractionated Heparin Product Category
Table United States Unfractionated Heparin Sales (K MT) by Region (2012-2017)
Table United States Unfractionated Heparin Sales Share by Region (2012-2017)
Figure United States Unfractionated Heparin Sales Share by Region (2012-2017)
Figure United States Unfractionated Heparin Sales Market Share by Region in 2016
Table United States Unfractionated Heparin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Unfractionated Heparin Revenue Share by Region (2012-2017)
Figure United States Unfractionated Heparin Revenue Market Share by Region (2012-2017)
Figure United States Unfractionated Heparin Revenue Market Share by Region in 2016
Table United States Unfractionated Heparin Price (USD/MT) by Region (2012-2017)
Table United States Unfractionated Heparin Sales (K MT) by Type (2012-2017)
Table United States Unfractionated Heparin Sales Share by Type (2012-2017)
Figure United States Unfractionated Heparin Sales Share by Type (2012-2017)
Figure United States Unfractionated Heparin Sales Market Share by Type in 2016
Table United States Unfractionated Heparin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Unfractionated Heparin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Unfractionated Heparin by Type (2012-2017)
Figure Revenue Market Share of Unfractionated Heparin by Type in 2016
Table United States Unfractionated Heparin Price (USD/MT) by Types (2012-2017)
Figure United States Unfractionated Heparin Sales Growth Rate by Type (2012-2017)
Table United States Unfractionated Heparin Sales (K MT) by Application (2012-2017)
Table United States Unfractionated Heparin Sales Market Share by Application (2012-2017)
Figure United States Unfractionated Heparin Sales Market Share by Application (2012-2017)
Figure United States Unfractionated Heparin Sales Market Share by Application in 2016
Table United States Unfractionated Heparin Sales Growth Rate by Application (2012-2017)
Figure United States Unfractionated Heparin Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Unfractionated Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Unfractionated Heparin Sales Growth Rate (2012-2017)
Figure Pfizer Unfractionated Heparin Sales Market Share in United States (2012-2017)
Figure Pfizer Unfractionated Heparin Revenue Market Share in United States (2012-2017)
Table Bayer Healthcare AG Basic Information List
Table Bayer Healthcare AG Unfractionated Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Healthcare AG Unfractionated Heparin Sales Growth Rate (2012-2017)
Figure Bayer Healthcare AG Unfractionated Heparin Sales Market Share in United States (2012-2017)
Figure Bayer Healthcare AG Unfractionated Heparin Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Unfractionated Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Unfractionated Heparin Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Unfractionated Heparin Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Unfractionated Heparin Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Unfractionated Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Unfractionated Heparin Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Unfractionated Heparin Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Unfractionated Heparin Revenue Market Share in United States (2012-2017)
Table Sanofi S.A Basic Information List
Table Sanofi S.A Unfractionated Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi S.A Unfractionated Heparin Sales Growth Rate (2012-2017)
Figure Sanofi S.A Unfractionated Heparin Sales Market Share in United States (2012-2017)
Figure Sanofi S.A Unfractionated Heparin Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Unfractionated Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Abbott Unfractionated Heparin Sales Growth Rate (2012-2017)
Figure Abbott Unfractionated Heparin Sales Market Share in United States (2012-2017)
Figure Abbott Unfractionated Heparin Revenue Market Share in United States (2012-2017)
Table Baxter Basic Information List
Table Baxter Unfractionated Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Baxter Unfractionated Heparin Sales Growth Rate (2012-2017)
Figure Baxter Unfractionated Heparin Sales Market Share in United States (2012-2017)
Figure Baxter Unfractionated Heparin Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Unfractionated Heparin
Figure Manufacturing Process Analysis of Unfractionated Heparin
Figure Unfractionated Heparin Industrial Chain Analysis
Table Raw Materials Sources of Unfractionated Heparin Major Players/Suppliers in 2016
Table Major Buyers of Unfractionated Heparin
Table Distributors/Traders List
Figure United States Unfractionated Heparin Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Unfractionated Heparin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Unfractionated Heparin Price (USD/MT) Trend Forecast (2017-2022)
Table United States Unfractionated Heparin Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Unfractionated Heparin Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Unfractionated Heparin Sales Volume (K MT) Forecast by Type in 2022
Table United States Unfractionated Heparin Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Unfractionated Heparin Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Unfractionated Heparin Sales Volume (K MT) Forecast by Application in 2022
Table United States Unfractionated Heparin Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Unfractionated Heparin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Unfractionated Heparin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Unfractionated Heparin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

captcha
Can't read the image? click here to refresh
* mark fields are compulsory